B. Ramms

发表

ApoC-III Glycoforms Are Differentially Cleared by Hepatic TRL (Triglyceride-Rich Lipoprotein) Receptors.

Richard G. Lee, J. Esko, M. Graham, 2019, Arteriosclerosis, thrombosis, and vascular biology.

ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors.

Richard G. Lee, J. Esko, J. Witztum, 2016, The Journal of clinical investigation.

Interventional hepatic apoC-III knockdown improves atherosclerotic plaque stability and remodeling by triglyceride lowering

J. Witztum, R. Crooke, S. Tsimikas, 2022, JCI insight.

ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance[S]

Christian M. Metallo, R. Krauss, C. Benner, 2019, Journal of Lipid Research.

Apolipoprotein C-III in triglyceride-rich lipoprotein metabolism

P. Gordts, B. Ramms, 2018, Current opinion in lipidology.

Deletion of Lymphangiogenic and Angiogenic Growth Factor VEGF-D Leads to Severe Hyperlipidemia and Delayed Clearance of Chylomicron Remnants

S. Ylä-Herttuala, M. Jauhiainen, M. Kaikkonen, 2018, Arteriosclerosis, thrombosis, and vascular biology.

Arylsulfatase K inactivation causes mucopolysaccharidosis due to deficient glucuronate desulfation of heparan and chondroitin sulfate.

T. Dierks, S. Stroobants, J. Esko, 2020, The Biochemical journal.

The Human Milk Oligosaccharide 3’Sialyllactose Promotes Inflammation Resolution and Reduces Atherosclerosis Development in Mice

C. Glass, N. Lewis, K. V. Grunddal, 2021, bioRxiv.

Systemic LSD1 inhibition prevents aberrant remodeling of metabolism in obesity

M. Sander, I. Omar, M. Wortham, 2021, bioRxiv.

Metabolic control of adaptive β-cell proliferation by the protein deacetylase SIRT2

Siyouneh Baghdasarian, O. Shirihai, Chun Zeng, 2024, bioRxiv.

Dietary nitrate struggles in atherosclerosis.

P. Gordts, B. Ramms, 2016, Atherosclerosis.